Why does standard cancer care so often fail? Because it’s based on averages, not on you.

In this episode, Dr. Dino Prato, founder of Envita Medical Centers, explains why the old model of “one-size-fits-all” oncology is broken — and how N of one precision oncology removes the guesswork. Instead of relying only on clinical trial averages, precision oncology analyzes thousands of data points unique to each tumor, including RNA transcriptomics, DNA genomics, immune profiling, spatial biology, and metabolomics.

Dr. Prato reveals how this approach delivers dramatically better outcomes for late-stage patients in Envita’s published clinical data — showing 34x better treatment responses, 43x better quality of life, and 95x fewer side effects compared to standard protocols.*
*(See Outcomes Disclaimer Below)

🎯 What You’ll Learn in This Episode:

• Why clinical trial “averages” fail patients with advanced cancers
• How iPredict and WINTHER trials proved genetic + transcriptomic matching improves survival
• The power of multi-omics: RNA, DNA, immune profiling, metabolomics, spatial biology
• How infections and toxins drive cancer growth and resistance
• Why guided, adaptive care outperforms trial-and-error regimens
• The essential questions every patient should ask their oncologist

In our experience, precision oncology is transforming care — from blind protocols to targeted treatments designed for each patient’s unique cancer fingerprint.

“Don’t settle for averages. Remove the guesswork and demand precision.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493